The COVID-19 Pandemic May Cause a Long-Term Disruption to Cancer Care

SAP Partners | Health System / Oncology | <b>Association of Community Cancer Centers</b>

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how the COVID-19 pandemic is going to impact cancer mortality.

Pharmacy Times® interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers and medical director at Ann B. Barshinger Cancer Institute, Penn Medicine in Lancaster PA about how the coronavirus disease 2019 (COVID-19) pandemic is going to impact cancer mortality.

The full conversation can be found in the video above.

Related Content:

Association of Community Cancer CentersInterviewsCoronavirusHospitalOncology
Understanding of Mutations Influences Treatment for Patients With Waldenstrom Macroglobulinemia
Clinical Overview: Empagliflozin for Type 2 Diabetes Patients With Cardiovascular Disease or Heart Failure, Reduced Ejection Fraction
Monjuvi Demonstrates Long-Term Efficacy for Individuals With R/R DLBCL